MY142617A - Dual specific ligands with increased serum half-life - Google Patents

Dual specific ligands with increased serum half-life

Info

Publication number
MY142617A
MY142617A MYPI20045336A MY142617A MY 142617 A MY142617 A MY 142617A MY PI20045336 A MYPI20045336 A MY PI20045336A MY 142617 A MY142617 A MY 142617A
Authority
MY
Malaysia
Prior art keywords
life
serum half
increased serum
specific ligands
dual specific
Prior art date
Application number
Inventor
Greg Winter
Ian Tomlinson
Olga Ignatovich
Lucy Holt
Elena De Angelis
Phillip Jones
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domantis Ltd filed Critical Domantis Ltd
Priority to MYPI20045336 priority Critical patent/MY142617A/en
Publication of MY142617A publication Critical patent/MY142617A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

THE INVENTION PROVIDES A DUAL-SPECIFIC LIGAND CORNPNSMQ A FIRST IMMUNOGLOBULIN VARIABLE DOMAIN HAVING A FIRST BINDING SPECIFICITY AND A COMPLEMENTARY OR NON-COMPLEMENTARY IMMUNOGLOBULIN VARIABLE DOMAIN HAVING A SECOND BINDING SPECIFICITY.
MYPI20045336 2004-12-23 2004-12-23 Dual specific ligands with increased serum half-life MY142617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20045336 MY142617A (en) 2004-12-23 2004-12-23 Dual specific ligands with increased serum half-life

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20045336 MY142617A (en) 2004-12-23 2004-12-23 Dual specific ligands with increased serum half-life

Publications (1)

Publication Number Publication Date
MY142617A true MY142617A (en) 2010-12-15

Family

ID=44256609

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20045336 MY142617A (en) 2004-12-23 2004-12-23 Dual specific ligands with increased serum half-life

Country Status (1)

Country Link
MY (1) MY142617A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11773159B2 (en) 2011-05-05 2023-10-03 Merck Patent Gmbh Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11773159B2 (en) 2011-05-05 2023-10-03 Merck Patent Gmbh Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

Similar Documents

Publication Publication Date Title
SI1517921T1 (en) Dual specific ligands with increased serum half-life
EA020464B9 (en) Antibody single variable domains against serum albumin
WO2004058821A3 (en) Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
DE60237282D1 (en) DOUBLE-SPECIFIC LIGAND AND ITS USE
WO2009058383A3 (en) Ligand
WO2008048970A3 (en) Synthetic antibodies
WO2006130374A3 (en) Tweak binding antibodies
WO2005086775A3 (en) Lumen-exposed molecules and methods for targeted delivery
WO2005047314A3 (en) Fgf-beta binding and supported peptides
AP2166A (en) Wear Edge assembly.
WO2004037979A3 (en) Improved sso7-polymerase conjugate proteins
AP2172A (en) Piping.
FR2865897B1 (en) MODULATORS FOR THE DEVELOPMENT OF MYCORRHIZIAN FUNGI WITH ARBUSCLES, AND.
AP2353A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands.
WO2005019270A3 (en) Endotheliase-2 ligands
IL199409A (en) Method for isolating an intestinal cholesterol binding protein, intestinal cholesterol binding protein, its complexes and uses thereof
WO2002065133A3 (en) Ligands used for detecting prions
WO2005019431A3 (en) Selective inhibition of toll-like receptor-2
CY1111435T1 (en) DOUBLE-SPECIAL CONNECTOR AND USE OF IT
WO2003091415A3 (en) Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color
WO2003057732A3 (en) Multispecific binding molecules
WO2007072022A3 (en) Composition comprising an antigen-recognizing molecule and a lipid-based carrier
EA200700683A1 (en) NEW ONE-CENTER CATALYST COMPONENT WITH METAL CONTAINING CHELATE MAIN CHAIN
WO2001061352A3 (en) Production of a protein biosensor with a defined binding matrix
UA98927C2 (en) Sclerostin binding antibody or fragment thereof